357 related articles for article (PubMed ID: 28604268)
41. Immunization with cell-free-generated vaccine protects from Porphyromonas gingivalis-induced alveolar bone loss.
Huang N; Shimomura E; Yin G; Tran C; Sato A; Steiner A; Heibeck T; Tam M; Fairman J; Gibson FC
J Clin Periodontol; 2019 Feb; 46(2):197-205. PubMed ID: 30578564
[TBL] [Abstract][Full Text] [Related]
42. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response.
Kohler JJ; Pathangey LB; Brown TA
Oral Microbiol Immunol; 1998 Apr; 13(2):81-8. PubMed ID: 9573798
[TBL] [Abstract][Full Text] [Related]
43. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss.
O'Brien-Simpson NM; Pathirana RD; Paolini RA; Chen YY; Veith PD; Tam V; Ally N; Pike RN; Reynolds EC
J Immunol; 2005 Sep; 175(6):3980-9. PubMed ID: 16148146
[TBL] [Abstract][Full Text] [Related]
44. Nasal immunization with a fusion protein consisting of the hemagglutinin A antigenic region and the maltose-binding protein elicits CD11c(+) CD8(+) dendritic cells for induced long-term protective immunity.
Du Y; Hashizume T; Kurita-Ochiai T; Yuzawa S; Abiko Y; Yamamoto M
Infect Immun; 2011 Feb; 79(2):895-904. PubMed ID: 21115722
[TBL] [Abstract][Full Text] [Related]
45. Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model.
Gibson FC; Gonzalez DA; Wong J; Genco CA
Infect Immun; 2004 Apr; 72(4):2408-11. PubMed ID: 15039370
[TBL] [Abstract][Full Text] [Related]
46. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
[TBL] [Abstract][Full Text] [Related]
47. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.
Liu C; Hashizume T; Kurita-Ochiai T; Fujihashi K; Yamamoto M
Mol Oral Microbiol; 2010 Jun; 25(3):178-89. PubMed ID: 20502628
[TBL] [Abstract][Full Text] [Related]
48. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
Shimauchi H
Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
[TBL] [Abstract][Full Text] [Related]
49. kgp, rgpA, and rgpB DNA vaccines induce antibody responses in experimental peri-implantitis.
Guo M; Wang Z; Fan X; Bian Y; Wang T; Zhu L; Lan J
J Periodontol; 2014 Nov; 85(11):1575-81. PubMed ID: 24921431
[TBL] [Abstract][Full Text] [Related]
50. The effect of monoclonal antibody and route of immunization on the humoral immune response against Porphyromonas gingivalis.
Van Tilburg ML; Kozarov EV; Progulske-Fox A; Brady LJ
Oral Microbiol Immunol; 2001 Jun; 16(3):153-62. PubMed ID: 11358537
[TBL] [Abstract][Full Text] [Related]
51. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215
[TBL] [Abstract][Full Text] [Related]
52. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses.
Koizumi Y; Kurita-Ochiai T; Yamamoto M
Oral Microbiol Immunol; 2008 Apr; 23(2):131-8. PubMed ID: 18279181
[TBL] [Abstract][Full Text] [Related]
53. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants.
Shin EA; Lee JY; Kim TG; Park YK; Langridge WH
Protein Expr Purif; 2006 May; 47(1):99-109. PubMed ID: 16275129
[TBL] [Abstract][Full Text] [Related]
55. Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinase-adhesin complex of Porphyromonas gingivalis in adult periodontitis.
O'Brien-Simpson NM; Black CL; Bhogal PS; Cleal SM; Slakeski N; Higgins TJ; Reynolds EC
Infect Immun; 2000 May; 68(5):2704-12. PubMed ID: 10768963
[TBL] [Abstract][Full Text] [Related]
56. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.
Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY
Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220
[TBL] [Abstract][Full Text] [Related]
57.
Fan X; Li X; Ren H; Lan J; Zhang S
Discov Med; 2024 Feb; 36(181):355-365. PubMed ID: 38409840
[TBL] [Abstract][Full Text] [Related]
58. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
59. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice.
Bittner-Eddy PD; Fischer LA; Costalonga M
Mol Oral Microbiol; 2013 Dec; 28(6):452-66. PubMed ID: 23945018
[TBL] [Abstract][Full Text] [Related]
60. Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis.
Gibson FC; Savelli J; Van Dyke TE; Genco CA
J Periodontol; 2005 Oct; 76(10):1629-36. PubMed ID: 16253083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
